Related Experiment Video
Updated: Nov 18, 2025
02:37
Robot-Assisted Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma
Published on: December 15, 2023
1.1K
Projected Cost Simulation in Chronic Ear Surgery: Cost in Chronic Ear Surgery
Kent Tadokoro1, Emily Bacalao2, Amy Wozniak3
1Department of Otolaryngology-Head and Neck Surgery, Loyola University Medical Center.
Summary
Intact canal wall tympanomastoidectomy has higher initial costs for chronic ear disease management. Canal wall down surgery becomes more expensive long-term due to mastoid cavity maintenance.
Area of Science:
- Otolaryngology
- Health Economics
- Surgical Outcomes
Background:
- Chronic ear disease management involves surgical interventions like intact canal wall (ICW) and canal wall down (CWD) tympanomastoidectomy.
- Recidivism rates of cholesteatoma are a significant factor in long-term patient outcomes and healthcare costs.
Purpose of the Study:
- To compare the projected healthcare costs of ICW and CWD tympanomastoidectomy, including follow-up visits.
- To analyze the long-term cost-effectiveness of different surgical approaches for chronic ear disease.
Main Methods:
- Literature review to assess cholesteatoma recidivism rates for ICW and CWD tympanomastoidectomy.
- Medicare cost simulation over 15 years, incorporating a 25% annual cholesteatoma recidivism rate.
Main Results:
- ICW tympanomastoidectomy showed a higher initial mean cost ($9112.06) compared to CWD ($4954.16) in the first year.
- Canal wall down surgery incurred greater accumulated costs over time due to the need for routine mastoid debridements.
- CWD costs surpassed ICW costs at approximately 12.54 years.
Conclusions:
- Intact canal wall tympanomastoidectomy presents a higher upfront healthcare cost.
- Canal wall down tympanomastoidectomy leads to higher long-term costs due to ongoing mastoid cavity maintenance, surpassing ICW costs after 12.54 years.
